- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 22, 2024, 01:31:31 PM
- Local Time:
- June 15, 2024, 06:35:28 PM
- Last Active:
- May 22, 2024, 05:40:43 PM
Signature:
Moreover, the roll-out of EPT strategies to cover HLA connected diseases and also pharmacogenetic side effects, such as HLA-B27, HLA*B*5701 and HLA-DQ